79 completed, 17 unknown, 12 terminated, 9 withdrawn. 129 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 129 | Completed 79, Unknown 17, Terminated 12, Withdrawn 9, Not yet recruiting 5, Recruiting 4, Active not recruiting 2, Enrolling by invitation 1 |
Follow Bronchitis: new trials by email Literature Review of Bronchitis trials Research Report on Bronchitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The LalelaLung Study: Digital Stethoscope Clinical Evaluation StethoMe AI-enabled digital stethoscope system, Standard IMCI assessment - Pneumonia, Tuberculosis, Pulmonary | Phase 4 | Not yet recruiting | Johns Hopkins University | 350 | 2026-12-07 | 2026-11-10 |
| A Study to Investigate Safety of Belumosudil in Participants Aged 12 Years and Above, With Chronic Graft-versus-host Disease (cGVHD) Belumosudil - Chronic Graft Versus Host Disease | Phase 4 | Not yet recruiting | Sanofi | 26 | 2026-11-20 | 2026-11-10 |
| Study to Evaluate the Effects of Oral Glyceryl Guiacolate (Guaifenesin, GGE) on Sputum Rheology in Subjects With Mucus Hypersecretion Glycerol Guiacolate, SOC (Standard of care) - Bronchitis, Bronchitis, Chronic | Phase 4 | Not yet recruiting | University of North Carolina, Chapel Hill | 40 | 2026-10-01 | 2026-10-14 |
| Anrikefon vs Nalfurafine for Sleep Quality in Hemodialysis Patients With CKD-aP Anrikefon, Nalfurafine - Pruritus Chronic, Kidney Diseases, Chronic | Phase 4 | Recruiting | Zhujiang Hospital | 50 | 2026-06-22 | 2026-08-25 |
| A Phase 4 Clinical Trial to Evaluate the Efficacy and Safety of CANIUM Tab. in Acute Bronchitis Patients. DSP2505(Canium), Umckamin, Placebo Matching Umckamin - Acute Bronchitis | Phase 4 | Completed | Dasan Pharmaceutical Co., Ltd. | 223 | 2026-01-26 | 2026-09-23 |
| Entecavir With or Without Pegylated Interferon α-2b in Children Aged 3-6 Years With Immune-Tolerant Chronic Hepatitis B Entecavir, Entecavir + Pegylated interferon α-2b - Hepatitis B Virus Infection, Children | Phase 4 | Not yet recruiting | Qing-Lei Zeng | 80 | 2026-01-11 | 2026-01-16 |
| Entecavir With or Without Pegylated Interferon α-2b in Children Aged 3-6 Years With Immune-Active Chronic Hepatitis B Entecavir, Entecavir + Pegylated interferon α-2b - Hepatitis B Virus Infection, Children | Phase 4 | Not yet recruiting | Qing-Lei Zeng | 60 | 2026-01-11 | 2026-01-16 |
| Pegmolesatide Treatment for Anemia in Patients Undergoing Long-term Dialysis The rHuEPO Monotherapy Group (Control Group), The Pegmolesatide and Roxadustat Combination Therapy Group (Exploratory Group), The Pegmolesatide Monotherapy Group (Experimental group) - Dialysis; Complications, Chronic Kidney Disease 5D | Phase 4 | Recruiting | Chinese PLA General Hospital | 240 | 2025-08-01 | 2025-09-12 |
| Efficacy of Elixirium Thymi Compositum in the Treatment of Acute Bronchitis in Pediatric Patients Elixirium thymi compositum (FoNo VIII.), Elixirium thymi compositum (FoNo VIII.) placebo - Acute Bronchitis | Phase 4 | Enrolling by invitation | Semmelweis University | 56 | 2025-07-01 | 2025-06-26 |
| Effect of Sevoflurane and Desflurane on Heme Oxygenase-1 Expression in Elective Cholecystectomy Sevoflurane Group, Desflurane Group - Cholecystitis, Chronic | Phase 4 | Withdrawn | Kocaeli City Hospital | 2025-06-01 | 2025-02-05 | |
| The Use of Cyproheptadine in Pediatric Feeding Disorders Cyproheptadine, Nutritional Counseling, Behavioral Counseling - Pediatric Feeding Disorder, Chronic, Avoidant Restrictive Food Intake Disorder | Phase 4 | Completed | University of Miami | 18 | 2024-12-30 | 2026-06-04 |
| A Clinical Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Belumosudil in Chinese Adolescents With cGVHD Who Have Had an Inadequate Response to Glucocorticoids or Other Systemic Therapies Belumosudil - Chronic Graft Versus Host Disease | Phase 4 | Completed | Sanofi | 6 | 2024-12-04 | 2026-05-27 |
| Clinical Study of Asciminib in Previously Treated Indian Patients With Ph+ CML-CP Without T315I Mutation and in Patients With Ph+ CML-CP With T315I Mutation Asciminib - Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic Phase | Phase 4 | Completed | Novartis Pharmaceuticals | 85 | 2024-11-28 | 2026-06-08 |
| Efficacy of Lavender Essential Oil Chest Wraps in Infants With Bronchiolitis Lavender essential oil 10%, diluted in 90% olive oil, Control - Bronchiolitis | Phase 4 | Recruiting | University Hospital, Geneva | 400 | 2023-12-07 | 2025-03-30 |
| Effect of the Inhaled Triple Therapies Over the Small Airway in Biomass Exposure Vilanterol / Umeclidinium (25/62.5 mcg), Fluthicasone / Vilanterol / Umeclidinium (100/25/62.5 mcg), Beclomethasone / Formoterol / Glycopyrronyum 100/6/12.5 mcg - COPD Bronchitis, Pollution Related Respiratory Disorder | Phase 4 | Unknown | National Institute of Respiratory Diseases, Mexico | 128 | 2023-11-15 | 2024-08-26 |
| The Efficacy and Safety of Atock Dry Syrup With Acute Bronchitis Patients Atock Dry Syrup with placebo patch, Tulobuterol patch with placebo dry syrup - Acute Bronchitis | Phase 4 | Recruiting | SamA Pharmaceutical Co., Ltd | 296 | 2023-11-10 | 2025-09-23 |
| A Study to Explore if Long-term Use of Mucinex Can Help With Symptoms in Patients With Stable Chronic Bronchitis. Guafenesin tablets - Chronic Bronchitis | Phase 4 | Completed | American Health Research | 82 | 2023-07-17 | 2026-03-20 |
| Evaluate the Efficacy and Safety of Acute Bronchitis Symptoms Improvement for Bronpass Tab. Compared to Erdos Capsule Bronpass Tab., Placebo of Erdos capsule, Erdos capsule - Acute Bronchitis | Phase 4 | Completed | Kwang-Ha Yoo | 110 | 2022-04-15 | 2023-09-14 |
| Immunogenicity and Safety of a Third Dose and Immune Persistence of BBIBP-Corv Vaccine in Elderly People With Chronic Bronchitis and COPD Inactivated COVID-19 vaccine - COVID-19, Chronic Bronchitis | Phase 4 | Unknown | China National Biotec Group Company Limited | 400 | 2021-12-01 | 2021-11-02 |
| Clinical Trial of MED HF10™ Spinal Cord Stimulation for the Treatment of Chronic Pain SCS Device Program Setting - Chronic, Intractable Back Pain and/or Leg Pain | Phase 4 | Active not recruiting | Nevro Corp | 25 | 2021-11-16 | 2026-06-29 |
Showing 20 of 129. Sign in to see all of them.
Bronchiolitis Obliterans Syndrome (53) · Pulmonary Disease, Chronic Obstructive (36) · Bronchitis, Chronic (33) · Emphysema (18) · Bronchiolitis (17) · Bronchiolitis Obliterans (6) · Bronchiolitis, Viral (5) · Pain (5) · Disease (4) · Low Back Pain (4) · Pneumonia (4) · Renal Insufficiency (4) · Renal Insufficiency, Chronic (4) · Respiratory Sounds (4)
Bronchial Diseases (129) · Respiratory Tract Diseases (129) · Lung Diseases, Obstructive (128) · Lung Diseases (126) · Infections (80) · Pathological Conditions, Signs and Symptoms (80) · Respiratory Tract Infections (72) · Pathologic Processes (61) · Bronchiolitis (59) · Disease Attributes (58) · Chronic Disease (56) · Immune System Diseases (54) · Organizing Pneumonia (53) · Bronchiolitis Obliterans (52)
Formoterol Fumarate (7) · Saline Solution, Hypertonic (6) · Azithromycin (5) · Dexamethasone (5) · Saline Solution (5) · Tiotropium Bromide (5) · telithromycin (5) · Oxygen (4) · Sodium Chloride (4) · Sugars (4) · Acetylcysteine (3) · Albuterol (3) · Epinephrine (3) · Budesonide (2) · Duloxetine Hydrochloride (2)
Sanofi (6) · Sumitomo Pharma America, Inc. (5) · University of Zurich (5) · Johns Hopkins University (4) · China National Biotec Group Company Limited (3) · Novartis Pharmaceuticals (3) · University of California, Los Angeles (3) · Jiangxi Qingfeng Pharmaceutical Co. Ltd. (2) · KU Leuven (2) · Qing-Lei Zeng (2) · Queen's University (2) · Universitaire Ziekenhuizen KU Leuven (2) · University of Miami (2) · Watson Pharmaceuticals (2) · Zhujiang Hospital (2)
United States (39) · Spain (12) · China (11) · Belgium (9) · Italy (9) · Canada (7) · Germany (6) · Mexico (6) · South Korea (6) · France (5) · United Kingdom (5) · India (4) · Netherlands (4) · Switzerland (4) · Turkey (Türkiye) (4)
Konrad E Bloch, MD (5) · Geert M Verleden, MD, PhD (3) · Talant M Sooronbaev, MD (3) · Denis E O'Donnell, MD (2) · Hanqing He (2) · Pablo Alonso Coello, PhD (2) · Qing-Lei Zeng, M.D. (2) · Aayush Khanal, MD (1) · Adel R Rizkala, PharmD, MS (1) · Allan D Struthers, BSc, MD, FRCP, FESC (1) · Allison E Williams, MD (1) · Alyn Morice, Professor (1) · An Mariman, MD (1)
PMID 34433773, PMID 12095178, PMID 15229100, PMID 16113473, PMID 17035697, PMID 17652648, PMID 18025315, PMID 19208459, PMID 19808130, PMID 19875685, PMID 20175406, PMID 20181491, PMID 20562124, PMID 20576731, PMID 20580216, PMID 20646715, PMID 20724742, PMID 21040167, PMID 21536692, PMID 21760724, PMID 22075098, PMID 22129562, PMID 22230827, PMID 22579125, PMID 22687487, PMID 23545917, PMID 23682979, PMID 23758233, PMID 23764683, PMID 24163386, PMID 24484754, PMID 24638046, PMID 24738609, PMID 24750558, PMID 24862342, PMID 25138332, PMID 26082623, PMID 26321593, PMID 26357896, PMID 26372728, PMID 26508124, PMID 26719947, PMID 26803397, PMID 27308826, PMID 28187400, PMID 28284475, PMID 28454553, PMID 28592289, PMID 28628884, PMID 29508715
R01AT007987 (2), 2014 (1), 2015 (1), 2017 (1), 2025 (1), N01MH090003 (1), P50HL084945 (1), R01DK109914 (1), R01HL133240 (1), R01HL139365 (1), R01NS057594 (1), R33HD109804 (1)